Carmen Mejía
- Oncology top 10%
- Metal complexes synthesis and properties 10
- Cancer Treatment and Pharmacology 3
- Inorganic Chemistry top 10%
-
- Synthesis and Characterization of Heterocyclic Compounds 2
- Ferrocene Chemistry and Applications 2
-
- Cancer, Hypoxia, and Metabolism 3
-
- Neuroblastoma Research and Treatments 6
-
- Cell death mechanisms and regulation 4
-
- Neuroscience and Neuropharmacology Research 2
- Co-authors
- Lena Ruíz-AzuaraEnrique Hernández–LemusMarcos Flores‐ÁlamoJuan Carlos García‐RamosTeresa García-GascaJesús Espinal‐EnríquezIván Imaz-RosshandlerAtaúlfo Martı́nez-Torres
- Journals
- PLoS ONE (1 paper)Cancer Research (1 paper)International Journal of Molecular Sciences (1 paper)
- Partner nations
- MexicoSpainUnited States
In The Last Decade
Carmen Mejía
27 papers receiving 477 citations
Peers
Comparison fields: 5 of 77
- Oncology 255
- Inorganic Chemistry 87
- Organic Chemistry 143
- Cancer Research 39
- Endocrine and Autonomic Systems 16
Countries citing papers authored by Carmen Mejía
This map shows the geographic impact of Carmen Mejía's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carmen Mejía with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carmen Mejía more than expected).
Fields of papers citing papers by Carmen Mejía
This network shows the impact of papers produced by Carmen Mejía. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carmen Mejía. The network helps show where Carmen Mejía may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Carmen Mejía, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 5 | |
| 3 | 2023 | 10 | |
| 4 | 2023 | 27 | |
| 5 | 2022 | 54 | |
| 6 | 2022 | 4 | |
| 7 | 2020 | 22 | |
| 8 | 2019 | 14 | |
| 9 | 2019 | 3 | |
| 10 | 2017 | 22 | |
| 11 | 2016 | 32 | |
| 12 | 2016 | 11 | |
| 13 | 2015 | 27 | |
| 14 | 2013 | 35 | |
| 15 | 2013 | 45 | |
| 16 | 2012 | 23 | |
| 17 | 2011 | 7 | |
| 18 | 2008 | 52 | |
| 19 | 2008 | 14 | |
| 20 | 2003 | 8 |
About Carmen Mejía
Carmen Mejía is a scholar working on Applied Microbiology and Biotechnology, Oncology and Neurology, having authored 29 papers that have together received 485 indexed citations. Recurring topics across this work include Metal complexes synthesis and properties (10 papers), Neuroblastoma Research and Treatments (6 papers), Cell death mechanisms and regulation (4 papers), Cancer, Hypoxia, and Metabolism (3 papers), Cancer Treatment and Pharmacology (3 papers), Synthesis and Characterization of Heterocyclic Compounds (2 papers), Ferrocene Chemistry and Applications (2 papers) and Neuroscience and Neuropharmacology Research (2 papers). The work is most often cited by research in Oncology (255 citations), Inorganic Chemistry (87 citations) and Organic Chemistry (143 citations). Carmen Mejía has collaborated with scholars based in Mexico, Spain and United States. Frequent co-authors include Lena Ruíz-Azuara, Enrique Hernández–Lemus, Marcos Flores‐Álamo, Juan Carlos García‐Ramos, Teresa García-Gasca, Jesús Espinal‐Enríquez, Iván Imaz-Rosshandler, Ataúlfo Martı́nez-Torres, Yanis Toledano‐Magaña and Ricardo Miledi. Their work appears in journals such as PLoS ONE, Cancer Research and International Journal of Molecular Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.